Visual display terminal syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. In line with the above CVS diagnostic criteria for Chinese and Western medicine and deficiency of liver-yin and kidney-yin standards for Chinese medicine; 2. Use VDT more than two hours per day; 3. duration of more than three months; 4. Aged 15-65 years old men and women; 5. Voluntary as a research object, signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Uncorrected ametropia and anisometropia; 2. Ocular muscle dysfunction, monocular paralysis of the eye pupil dilation, and early-stage open-angle glaucoma; 3. Eye other active lesions, such as uveitis, eye infections; 4. If anxious, Hamilton Anxiety Scale (HAMA) total score> 14 or <7 points; 5. Endocrine disorders, neurasthenia, neurosis and high blood pressure and other patients; 6. recent history of eye surgery or trauma; 7. Pregnancy, breast-feeding women and the recent planning of pregnant women and mental patients; 8. combined with cardiovascular, cerebrovascular and hematopoietic system and other serious systemic diseases; 9. Allergic constitution or known to be allergic to the drug; 10. Those who used anti-fatigue drugs within 2 weeks before the experiment; 11. Participated in clinical trials of other drugs within 4 weeks before the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dry eye score and points;Visual fatigue symptom score;Hamilton Anxiety Scale (HAMA) total score;Brightness Persistence;Close tolerance with the time the eye;Chinese medicine symptom score 50% reduction rate;The main symptoms disappeared; | — |
Countries
China
Contacts
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine